|
WDFY1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.92249999994865E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.8042999961927E-08 |
| Normal-vs-Stage2 |
6.170300E-02 |
| Normal-vs-Stage3 |
9.736300E-02 |
| Normal-vs-Stage4 |
4.612000E-02 |
| Stage1-vs-Stage2 |
2.592200E-01 |
| Stage1-vs-Stage3 |
2.286400E-01 |
| Stage1-vs-Stage4 |
2.975900E-02 |
| Stage2-vs-Stage3 |
8.709400E-01 |
| Stage2-vs-Stage4 |
6.135400E-01 |
| Stage3-vs-Stage4 |
7.603800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.46290000002658E-06 |
| Normal-vs-AfricanAmerican |
6.735800E-01 |
| Normal-vs-Asian |
2.143000E-01 |
| Caucasian-vs-AfricanAmerican |
3.217700E-03 |
| Caucasian-vs-Asian |
9.265200E-01 |
| AfricanAmerican-vs-Asian |
1.896420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.790700E-04 |
| Normal-vs-Female |
7.56990000017055E-07 |
| Male-vs-Female |
1.277200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.382600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.82981999999887E-05 |
| Normal-vs-Age(61-80Yrs) |
5.612900E-04 |
| Normal-vs-Age(81-100Yrs) |
5.481400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.826400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.220600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.554200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.909000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.923410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.069400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.497600E-03 |
| Normal-vs-Grade 2 |
5.50879999949849E-07 |
| Normal-vs-Grade 3 |
8.418400E-03 |
| Normal-vs-Grade 4 |
3.925800E-01 |
| Grade 1-vs-Grade 2 |
3.819000E-01 |
| Grade 1-vs-Grade 3 |
2.118200E-03 |
| Grade 1-vs-Grade 4 |
1.123550E-03 |
| Grade 2-vs-Grade 3 |
1.880190E-03 |
| Grade 2-vs-Grade 4 |
5.224500E-04 |
| Grade 3-vs-Grade 4 |
2.440400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.5287999712923E-11 |
| Normal-vs-ccB subtype |
4.097700E-02 |
| ccA subtype-vs-ccB subtype |
1.197920E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.008400E-04 |
| Normal-vs-N1 |
2.538000E-01 |
| N0-vs-N1 |
8.655000E-01 |
|
|
